Display options
Cite
Li K, Luo J. The role of SIRT1 in tumorigenesis. N Am J Med Sci (Boston). 2011;4(2):104-106doi: 10.7156/v4i2p104.
Li, K., & Luo, J. (2011). The role of SIRT1 in tumorigenesis. North American journal of medicine & science, 4(2), 104-106. https://doi.org/10.7156/v4i2p104
Li, Kai, and Luo, Jianyuan. "The role of SIRT1 in tumorigenesis." North American journal of medicine & science vol. 4,2 (2011): 104-106. doi: https://doi.org/10.7156/v4i2p104
Li K, Luo J. The role of SIRT1 in tumorigenesis. N Am J Med Sci (Boston). 2011;4(2):104-106. doi: 10.7156/v4i2p104. PMID: 22180829; PMCID: PMC3237400.
Copy Download .nbib Format: NLM
Share it on

N Am J Med Sci (Boston). 2011;4(2):104-106. doi: 10.7156/v4i2p104.

The role of SIRT1 in tumorigenesis.

North American journal of medicine & science

Kai Li, Jianyuan Luo

Affiliations

  1. Department of Medical & Research Technology, Department of Pathology, School of Medicine, University of Maryland, AHB 405A, 100 Penn Street, Baltimore, MD 21201.

PMID: 22180829 PMCID: PMC3237400 DOI: 10.7156/v4i2p104

Abstract

NAD-dependent Class III histone deacetylase SIRT1 is a multiple functional protein and has been demonstrated critically involved in stress response, cellular metabolism and aging through deacetylating variety of substrates including p53, forkhead transcription factors, PGC-1α, NF-κB, Ku70 and histones. Increasing evidences indicate that SIRT1 plays a complex role in tumorigenesis with functions in both tumor promoting and tumor suppressing. This review provides an overview of current knowledge of SIRT1 and its controversies regarding the functions of SIRT1 in tumorigenesis.

References

  1. Science. 2004 Mar 26;303(5666):2011-5 - PubMed
  2. Nature. 2008 Jan 31;451(7178):587-90 - PubMed
  3. Cell. 2001 Oct 19;107(2):149-59 - PubMed
  4. Science. 2000 Sep 22;289(5487):2126-8 - PubMed
  5. Nat Rev Cancer. 2001 Nov;1(2):157-62 - PubMed
  6. Cold Spring Harb Symp Quant Biol. 2000;65:297-302 - PubMed
  7. Genes Dev. 1999 Oct 1;13(19):2570-80 - PubMed
  8. Nature. 2006 Nov 16;444(7117):337-42 - PubMed
  9. Cancer Cell. 2008 May;13(5):454-63 - PubMed
  10. Cancer Res. 2007 Jul 15;67(14):6612-8 - PubMed
  11. Cancer Res. 2006 Apr 15;66(8):4368-77 - PubMed
  12. Biochem J. 2007 Nov 1;407(3):451-60 - PubMed
  13. Cell Metab. 2009 Apr;9(4):327-38 - PubMed
  14. Genes Dev. 2000 May 1;14(9):1021-6 - PubMed
  15. Nature. 2008 Jan 31;451(7178):583-6 - PubMed
  16. Nat Cell Biol. 2006 Sep;8(9):1025-31 - PubMed
  17. Med Hypotheses. 2006;67(2):341-4 - PubMed
  18. Nat Cell Biol. 2002 Nov;4(11):859-64 - PubMed
  19. Cell. 2008 Nov 28;135(5):907-18 - PubMed
  20. PLoS One. 2008 Apr 16;3(4):e2020 - PubMed
  21. Genes Dev. 2009 Dec 15;23(24):2812-7 - PubMed
  22. Cancer Cell. 2008 Oct 7;14(4):312-23 - PubMed
  23. Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15998-6003 - PubMed
  24. EMBO J. 2004 Jun 16;23(12):2369-80 - PubMed
  25. Mol Cell Biol. 2010 Oct;30(19):4712-21 - PubMed
  26. Cell. 2001 Oct 19;107(2):137-48 - PubMed
  27. Mol Cell. 2007 Jul 6;27(1):149-62 - PubMed
  28. Cell Metab. 2010 Jul 7;12(1):78-87 - PubMed
  29. Nat Rev Cancer. 2008 Jan;8(1):61-70 - PubMed
  30. Mol Cell Biol. 2003 Jan;23(1):38-54 - PubMed
  31. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10794-9 - PubMed
  32. Mol Cell. 2010 Jul 30;39(2):247-58 - PubMed
  33. Mol Cell. 2008 Oct 10;32(1):11-20 - PubMed
  34. Cancer Res. 2005 Nov 15;65(22):10457-63 - PubMed
  35. Exp Mol Med. 2007 Feb 28;39(1):8-13 - PubMed
  36. Arch Dermatol Res. 2007 May;299(2):103-6 - PubMed
  37. Nat Commun. 2010 Apr 12;1:3 - PubMed
  38. Biotechnol J. 2007 Nov;2(11):1360-8 - PubMed
  39. Genes Dev. 2008 Jul 1;22(13):1753-7 - PubMed
  40. Oncogene. 2006 Sep 25;25(43):5854-63 - PubMed
  41. Nature. 2001 Mar 8;410(6825):227-30 - PubMed
  42. Cell. 2004 Feb 20;116(4):551-63 - PubMed
  43. Oncogene. 2006 Jan 12;25(2):176-85 - PubMed
  44. Leukemia. 2005 Oct;19(10):1751-9 - PubMed
  45. EMBO J. 2002 May 15;21(10):2383-96 - PubMed
  46. J Biol Chem. 2008 Mar 21;283(12):7590-8 - PubMed

Publication Types

Grant support